New study aims to stop postpartum bleeding in At-Risk moms
NCT ID NCT07353281
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two medicines—carbetocin (given through a vein) and misoprostol (given as a rectal tablet)—to see which works better at preventing dangerous heavy bleeding after vaginal delivery in women with risk factors. About 146 women will take part. The goal is to find the safest, most effective way to protect mothers from postpartum hemorrhage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM COMPLICATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple calcium tablet help prevent postpartum bleeding?
- Medical glue vs. internal bleeding: a new hope?
- Which drug stops Post-Birth bleeding better? a Head-to-Head test
- Could a simple calcium injection prevent dangerous bleeding after childbirth?
- Blood-Clotting showdown: which device best guides bleeding care in High-Risk patients?
- Simple C-Section techniques could slash postpartum bleeding risk